Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Total Debt (2020 - 2026)

Bioventus filings provide 6 years of Total Debt readings, the most recent being $279.0 million for Q4 2025.

  • On a quarterly basis, Total Debt fell 16.89% to $279.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $279.0 million, a 16.89% decrease, with the full-year FY2025 number at $279.0 million, down 16.89% from a year prior.
  • Total Debt hit $279.0 million in Q4 2025 for Bioventus, down from $322.6 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $445.6 million in Q2 2023 to a low of $175.8 million in Q4 2021.
  • Median Total Debt over the past 5 years was $367.7 million (2022), compared with a mean of $342.9 million.
  • Biggest five-year swings in Total Debt: skyrocketed 141.38% in 2022 and later fell 16.89% in 2025.
  • Bioventus' Total Debt stood at $357.7 million in 2021, then grew by 16.88% to $418.1 million in 2022, then fell by 12.22% to $367.0 million in 2023, then dropped by 8.55% to $335.6 million in 2024, then dropped by 16.89% to $279.0 million in 2025.
  • The last three reported values for Total Debt were $279.0 million (Q4 2025), $322.6 million (Q3 2025), and $341.2 million (Q2 2025) per Business Quant data.